You searched for "cancer"
Conference Report: The Medical Ophthalmology Society UK (MOSUK) 26th Annual Meeting
The Medical Ophthalmology Society UK (MOSUK) held its 26th annual meeting on 26 February 2025 at the International Students House in Great Portland Street, London. Medical ophthalmology is a distinctive and holistic speciality that encompasses the investigation, diagnosis, and management...African-Caribbean ethnicity key risk factor for sight-threatening diabetic eye disease
People of African-Caribbean ethnicity with Type 2 diabetes are a third more likely to develop a condition called sight-threatening diabetic retinopathy (STDR) than other ethnic groups, according to researchers from King’s College London. The study, published in the journal Diabetes...The eye surgeon and eye physician together: the joint ophthalmic clinic
Since the early 19th century, physicians and surgeons have been working together in eye clinics and hospitals to bring about the best outcome for the patients. From the early Babylonian age, important advances in ophthalmic knowledge arose in a stuttered...OCT in neuro-ophthalmology: A practical overview
From multiple sclerosis to raised intracranial pressure, optical coherence tomography is transforming how we diagnose, monitor and predict outcomes across the full spectrum of neuro-ophthalmic disease. Optical coherence tomography (OCT) is a rapid imaging method that utilises light waves to...What’s trending Feb/Mar 2026
A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #Darts #AlyPaly It always looks like an electric atmosphere at Alexandra Palace for the World Darts Championship, and the 2025/2026 competition...
Quality of life concerns after uveal melanoma diagnosis
The authors sought to investigate factors associated with Quality Of Life (QOL) after initial diagnosis of uveal melanoma (UM) using prospectively collected data between September 2011-May 2016. They included 201 participants referred for radiotherapy after UM diagnosis by an ophthalmic...
Intravitreal Ziv-Aflibercept: safety analysis
Ziv-Aflibercept (Zaltrap; Sanofi-Aventis U.S LLS, Bridgewater, NJ) was originally introduced as an intravenous formulation for metastatic colorectal cancer. The adoption of Ziv-Aflibercept in ophthalmic practice was similar to bevacizumab, and reports have previously examined one to two year visual outcomes...
Exploring the potential of neurodegenerative disease screening within age-related eye disease research
The authors recruited healthy controls aged between 60 and 75-years-old, previously enrolled into a registry as patients following cataract surgery without age-related macular degeneration (AMD). Exclusion criteria included dense cataract, retinal disease, ocular inflammatory disease, moderate glaucoma, optic neuropathy, cancer,...
